Heterocyclic substituted bisarylurea derivatives

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C514S340000, C514S395000, C544S279000, C546S272400, C548S255000

Reexamination Certificate

active

08003657

ABSTRACT:
The present invention relates to heterocyclic substituted bisarylurea derivatives of formula I, the use of the compounds of formula I as inhibitors of one or more kinases, the use of the compounds of formula I for the manufacture of a pharmaceutical composition and a method of treatment, comprising administering said pharmaceutical composition to a patient.

REFERENCES:
patent: 2003/0027914 (2003-02-01), Suzuki et al.
patent: 2003/0144278 (2003-07-01), Riedl et al.
patent: 2004/0014756 (2004-01-01), Michaelides et al.
patent: 99/32436 (1999-07-01), None
patent: 01/51456 (2001-07-01), None
patent: 01/57008 (2001-08-01), None
patent: 02/44156 (2002-06-01), None
patent: 02/092576 (2002-11-01), None
patent: 03/068223 (2003-08-01), None
patent: WO 03/099771 (2003-12-01), None
patent: 2005/075425 (2005-08-01), None
West, Anthony R., Solid State Chemistry and its Applications, Wiley, New York, 1988, pp. 358 & 365.
Manley et al., Urea derivatives of STI571 as inhibitors of Bcr-Abl and PDGFR kinases, Bioorganic & Medicinal Chemistry Letters, vol. 14, Issue 23, pp. 5793-5797, (2004) .

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Heterocyclic substituted bisarylurea derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Heterocyclic substituted bisarylurea derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Heterocyclic substituted bisarylurea derivatives will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-2662630

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.